These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 888119)

  • 1. Properties and radioimmunoassay of canine factor X.
    Arai H; Takeda Y
    Thromb Res; 1977 Jul; 11(1):57-66. PubMed ID: 888119
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicochemical and immunological properties of canine factor X and activated factor X.
    Arai H; Takeda Y
    Thromb Res; 1977 Sep; 11(3):357-64. PubMed ID: 411192
    [No Abstract]   [Full Text] [Related]  

  • 3. A form of bovine factor X with a single polypeptide chain.
    Mattock P; Esnouf MP
    Nat New Biol; 1973 Mar; 242(116):90-2. PubMed ID: 4512238
    [No Abstract]   [Full Text] [Related]  

  • 4. A method for the simultaneous isolation of factor X and prothrombin from bovine plasma.
    Esnouf MP; Lloyd PH; Jesty J
    Biochem J; 1973 Apr; 131(4):781-9. PubMed ID: 4737324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radioimmunoassay of factor X.
    Murphy RF; Elmore DT
    Thromb Res; 1977 Nov; 11(5):693-4. PubMed ID: 929516
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of heparin, typhoid vaccine and thrombophlebitis on factor X metabolism in the dog.
    Takeda Y; Arai H
    Thromb Haemost; 1978 Aug; 40(1):118-27. PubMed ID: 725842
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunochemical techniques for studying coagulation proteins.
    Jenny RJ; Messier TL; Ouellette LA; Church WR
    Methods Enzymol; 1993; 222():400-16. PubMed ID: 8412807
    [No Abstract]   [Full Text] [Related]  

  • 8. Bovine factors X 1 and X 2 (Stuart factor). Isolation and characterization.
    Fujikawa K; Legaz ME; Davie EW
    Biochemistry; 1972 Dec; 11(26):4882-91. PubMed ID: 4629382
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.
    van Wijk EM; Kahlé LH; ten Cate JW
    Clin Chem; 1980 Jun; 26(7):885-90. PubMed ID: 7379310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of bovine factor X activated in concentrated sodium citrate solution.
    Radcliffe RD; Barton PG
    Arch Biochem Biophys; 1973 Apr; 155(2):381-90. PubMed ID: 4735850
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of human factor X and comparison of peptide maps of human factor X and prothrombin.
    Aronson DL; Mustafa AJ; Mushinski JF
    Biochim Biophys Acta; 1969 Aug; 188(1):25-30. PubMed ID: 5820683
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined functional and immunochemical analysis of normal and abnormal human factor X.
    Fair DS; Plow EF; Edgington TS
    J Clin Invest; 1979 Oct; 64(4):884-94. PubMed ID: 90058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some characteristics of the Coagulation Factor Xa purified from human serum.
    Berre AG; Osterud B; Christensen TB; Holm T; Prydz H
    Biochem J; 1973 Dec; 135(4):791-5. PubMed ID: 4778275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the apparent thrombogenicity of thrombin.
    Yin ET; Wessler S
    Thromb Diath Haemorrh; 1968 Dec; 20(3):465-8. PubMed ID: 5751636
    [No Abstract]   [Full Text] [Related]  

  • 15. Canine immunoreactive insulin quantitation using, five commercial radioimmunoassay kits.
    Stockham SL; Nachreiner RF; Krehbiel JD
    Am J Vet Res; 1983 Nov; 44(11):2179-83. PubMed ID: 6359984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The purification and properties of factor X from pig serum and its role in hypercoagulability in vivo.
    Dupe RJ; Howell RM
    Biochem J; 1973 Jun; 133(2):311-21. PubMed ID: 4723777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor X antigen evaluation by means of a laser nephelometer in health and disease.
    Girolami A; Ruzza G; Cappellato MG; Vicarioto MA
    Clin Chim Acta; 1985 May; 148(2):125-30. PubMed ID: 3995780
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity and antigen of coagulation factors VII and X in five patients with abnormal chromosome 13.
    Fukushima Y; Kuroki Y; Iizuka A
    Jinrui Idengaku Zasshi; 1987 Jun; 32(2):91-6. PubMed ID: 3437574
    [No Abstract]   [Full Text] [Related]  

  • 19. Conformation-specific antibodies: approach to the study of the vitamin K-dependent blood coagulation proteins.
    Furie B; Blanchard RA; Robison DJ; Tai MM; Furie BC
    Methods Enzymol; 1982; 84():60-83. PubMed ID: 7098972
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of the coagulation factors VII and X from human serum. Some properties of factor VII.
    Gladhaug A; Prydz H
    Biochim Biophys Acta; 1970 Jul; 215(1):105-11. PubMed ID: 5494503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.